Axiom Investors’s Gilead Sciences GILD Stock Holding History

Axiom Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-385,870	Closed	-$32.2M	–	152
2016 Q2	$32.2M	Sell	385,870 -129,826	-25%	-$11.5M	0.93%	40
2016 Q1	$47.4M	Sell	515,696 -23,120	-4%	-$2.08M	1.47%	27
2015 Q4	$54.5M	Sell	538,816 -38,490	-7%	-$4.01M	1.76%	21
2015 Q3	$56.7M	Buy	577,306 +241,306	+72%	+$26.8M	1.79%	18
2015 Q2	$39.3M	Buy	+336,000	New	+$36.7M	1.13%	42
2014 Q4	–	Sell	-815,410	Closed	-$86.8M	–	165
2014 Q3	$86.8M	Sell	815,410 -26,870	-3%	-$2.63M	2.15%	10
2014 Q2	$69.8M	Sell	842,280 -61,450	-7%	-$4.78M	1.64%	20
2014 Q1	$64M	Sell	903,730 -28,620	-3%	-$2.24M	1.53%	21
2013 Q4	$70M	Sell	932,350 -44,750	-5%	-$3.12M	1.87%	13
2013 Q3	$61.4M	Buy	977,100 +204,150	+26%	+$12.2M	1.96%	12
2013 Q2	$39.6M	Buy	+772,950	New	+$40.3M	1.44%	27

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Axiom Investors's GILD Position: Q3 2016 in Review

Axiom Investors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 385,870 shares — an estimated $32.2M sold.

Axiom Investors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $86.8M in Q3 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Axiom Investors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Axiom Investors sold 385,870 Gilead Sciences shares in Q3 2016, an estimated $32.2M.
Axiom Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Axiom Investors's Gilead Sciences position peaked at $86.8M in Q3 2014.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Axiom Investors's 13F filing for Q3 2016, filed 14 Nov 2016.